Dual Recovery Blend
Wolverine (BPC-157 + TB-500)
A BPC-157 + TB-500 research blend — two of the most-studied regenerative peptides — investigated for synergistic tissue repair and recovery. ≥99% purity, lyophilized, batch-specific COA. Laboratory research use only.
Product Details
Wolverine is a research blend combining two of the most-studied regenerative peptides — BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4) — to investigate synergistic tissue repair and recovery.
Why these two are paired
BPC-157 and TB-500 are frequently studied together because they engage repair through complementary mechanisms: BPC-157 is associated with cytoprotective and angiogenic (blood-vessel-forming) signaling, while TB-500 acts through actin regulation and cell migration. Pairing a cytoprotective/angiogenic agent with a cell-migration agent is the rationale behind the combination in recovery research.
Research context
Both components are among the most-studied peptides in the tissue-repair literature. This research-grade blend is supplied for in-vitro and laboratory study only. For full mechanism and literature, see our BPC-157 Research Overview » and TB-500 Research Overview ».
Prefer a different format? We also supply standalone BPC-157 » and TB-500 », and the triple-blend GLOW (BPC-157 + GHK-Cu + TB-500) », which adds the copper peptide GHK-Cu for a skin-and-recovery focus. Browse all Recovery Research » compounds.
Purity & testing
– ≥99% purity (this lot: 99.73% by HPLC)
– Lyophilized powder for laboratory reconstitution
– Batch-specific Certificate of Analysis — HPLC + mass spec, heavy metals, sterility, endotoxin
– ISO/IEC 17025-accredited third-party testing →View the COA »
Laboratory handling
Store lyophilized material cold and protected from light (long-term at −20 °C). After reconstitution, refrigerate at 2–8 °C and use within your protocol window. Confirm identity and purity against the batch COA before use.
Research FAQ
Why combine BPC-157 with TB-500? They engage tissue repair through different mechanisms — cytoprotective/angiogenic signaling (BPC-157) versus actin-regulated cell migration (TB-500) — so they’re studied together for a complementary effect.
How is this different from GLOW? GLOW adds a third peptide, the copper complex GHK-Cu, shifting the focus toward skin regeneration alongside recovery.
For laboratory and research use only. Not for human or veterinary consumption, and not for diagnostic or therapeutic use. These statements have not been evaluated by the FDA.



